Who invested in Intra-Cellular Therapies?
Intra-Cellular Therapies's investors include Deerfield and Broadfin Capital.
United States · Funded startup
3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Intra-Cellular Therapies and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$135Mraised across 3 rounds since 2013, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $60M sold, first sale Aug 2013
No investor was named in the report.
Reported by sec.govSEC filing: $60M sold, first sale Aug 2013
No investor was named in the report.
Reported by sec.govSEC filing: $15M sold, first sale Oct 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Intra-Cellular Therapies's investors include Deerfield and Broadfin Capital.
Intra-Cellular Therapies has raised $135M across 3 rounds since 2013.
Intra-Cellular Therapies's most recent round was a Secondary of $60M in Sept 2013.
Its most recent round, $60M in Sept 2013, is also its largest on record.
Intra-Cellular Therapies's first round on record, in Sept 2013, was backed by Deerfield and Broadfin Capital.
Intra-Cellular Therapies's latest named round is a Secondary, in Sept 2013.
Intra-Cellular Therapies is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.